Altered insulin requirement in patients with type 1 diabetes and primary adrenal insuffciency receiving standard glucocorticoid replacement therapy

European Journal of Endocrinology

Volumn 160, Issue 6, 2009, Pages 919-924

  Elbelt, Ulf ^a,b   Hahner, Stefanie ^a   Allolio, Bruno ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; INSULIN DERIVATIVE; LEVOTHYROXINE; LIOTHYRONINE; GLUCOCORTICOID;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LYMPHOCYTIC THYROIDITIS; METABOLIC REGULATION; MICROALBUMINURIA; MORNING DOSAGE; PRIORITY JOURNAL; STOMACH PARESIS; SUBTOTAL THYROIDECTOMY; TRISOMY 21; VITILIGO; ADDISON DISEASE; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADDISON DISEASE; ADULT; AGED; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGLYCEMIA; INSULIN; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE; RETROSPECTIVE STUDIES;

EID: 66149093416     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-1003     Document Type: Article

References (26)

1. Betterle C, Volpato M, Greggio AN & Presotto F. Type 2 polyglandular autoimmune disease. Journal of Pediatric Endocrinology and Metabolism 1996 9 113-123.
2. Betterle C & Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Bio Medica 2003 74 9-33.
3. Neufeld M, MaClaren NK & Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine 1981 60 355-362.
4. Betterle C, Dal Pra C, Mantero F & Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Reviews 2002 23 327-364.
5. Schroter W, Arends J, Runte L, Spelzhaus A, Neumeyer H, Talaulicar M, Boustani A & Willms B. Hypoglycemia with loss of consciousness during insulin therapy as an initial symptom of Addison's disease. Report of 2 cases. Deutsche Medizinische Wochenschrift 1985 110 840-842.
6. Armstrong L & Bell PM. Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ 1996 312 1601-1602.
7. Phornphutkul C, Boney CM & Gruppuso PA. A novel presentation of Addison's disease: hypoglycemia unawareness in an adolescent with insulin-dependent diabetes mellitus. Journal of Pediatrics 1998 132 882-884.
8. McAulay V & Frier BM. Addison's disease in type 1 diabetes presenting with recurrent hypoglycaemia. Postgraduate Medical Journal 2000 76 230-232.
9. Thomas JB, Petrovsky N & Ambler GR. Addison's disease presenting in four adolescents with type 1 diabetes. Pediatric Diabetes 2004 5 207-211.
10. Brewer KW, Parziale VS & Eisenbarth GS. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency. New England Journal of Medicine 1997 337 202.
11. Likhari T, Magzoub S, Griffiths MJ, Buch HN & Gama R. Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia. Postgraduate Medical Journal 2007 83 420-421.
12. Burke G & Emanuel B. Addison's disease and diabetes mellitus in an adolescent. Clinical Pediatrics 1965 4 543-547.
13. Lovas K, Loge JH & Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 2002 56 581-588.
14. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W & Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 2007 92 3912-3922.
15. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893.
16. Müller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jörgens V, Berger M & Mühlhauser I. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care 1999 22 B29-B34.
17. Kehlet H, Binder C & Blichert-Toft M. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clinical Endocrinology 1976 5 37-41.
18. Arlt W, Rosenthal C, Hahner S & Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clinical Endocrinology 2006 64 384-389.
19. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R & Weetman AP. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology 1997 46 255-261.
20. The Diabetes Control and Complications Trail Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 977-986.
21. Plat L, Leproult R, L'Hermite-Baleriaux M, Fery F, Mockel J, Polonsky KS & Van Cauter E. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. Journal of Clinical Endocrinology and Metabolism 1999 84 3082-3092.
22. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Grominca-Ihle E, Jeka S, Krueger K, Szechinski J & Alten R. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trail. Lancet 2008 371 205-214.
23. Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT & Ross RJ. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clinical Endocrinology 2008 68 130-135.
24. Ajaz F, Kudva YC & Erwin PJ. Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature. Endocrine Practice 2007 13 384-388.
25. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. New England Journal of Medicine 2004 350 2272-2279.
26. Wurtman RJ & Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. Journal of Biological Chemistry 1966 241 2301-2305.